Product from:
Preussen
675€
Only a few items left
ASS Dexcel Protect 75 mg gastro-resistant tablets by ASS are designed to help prevent blood clots. Each tablet contains 75 mg of acetylsalicylic acid to inhibit platelet aggregation. This medicine is used as part of standard therapy for unstable angina, acute myocardial infarction, and reinfarction prevention. This pack contains 100 tablets. Please note that this product contains lactose.
Zu Risiken und Nebenwirkungen lesen Sie die Packungsbeilage und fragen Sie Ihre Ärztin, Ihren Arzt oder in Ihrer Apotheke.
Description
You're reading an Auto-translation.
Important notes (mandatory information)
ASS Dexcel Protect 75 mg, enteric-coated tablets. Active ingredient: acetylsalicylic acid. Areas of application: for unstable angina pectoris (heart pain due to circulatory disorders in the coronary arteries) - as part of standard therapy, for acute heart attack - as part of standard therapy, for the prevention of another heart attack after the first heart attack (for reinfarction prophylaxis), after operations or other interventions on arterial blood vessels (after arterial vascular surgery or interventional procedures, e.g. after aortocoronary vein bypass [ACVB], with percutaneous transluminal coronary angioplasty [PTCA]) and for the prevention of transient cerebral ischemia (TIA: transient ischemic attacks) and cerebral infarction after prodromal symptoms (e.g. transient paralysis in the face or arm muscles or transient loss of vision) have occurred.For risks and side effects, read the package leaflet and ask your doctor or pharmacist.
This information was last revised in November 2014.
Source: Information from the package leaflet
Status: 06/2018
Active ingredient: acetylsalicylic acid. Areas of application: for unstable angina pectoris (heart pain due to circulatory disorders in the coronary arteries) - as part of standard therapy, for acute heart attack - as part of standard therapy, for the prevention of another heart attack after the first heart attack (for reinfarction prophylaxis), after operations or other interventions on arterial blood vessels (after arterial vascular surgery or interventional procedures, e.g. after aortocoronary vein bypass [ACVB], with percutaneous transluminal coronary angioplasty [PTCA]) and for the prevention of transient cerebral ischemia (TIA: transient ischemic attacks) and cerebral infarction after prodromal symptoms (e.g. transient paralysis in the face or arm muscles or transient loss of vision) have occurred.
Information leaflet
Download the information leafletComposition & Allergens
Composition
Wirkstoff: Acetylsalicylsäure




























